Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Dyadic International, Inc. - Common Stock (NQ:DYAI)

0.8900 -0.0100 (-1.11%)
Streaming Delayed Price Updated: 10:45 AM EST, Jan 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Dyadic International, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Santa’s Rally: CMCT, SURG, SIDU, MYSE, AZI – Stocks Under $5 to Watch Now – More Inside
Via AB Newswire
Topics Artificial Intelligence
News headline image
Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutrition, and Bioindustrial Markets
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic’s Recombinant Growth Factors and Media Proteins
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Updated Lineup Announced for iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025
Via ACCESS Newswire
News headline image
iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025
Via ACCESS Newswire
News headline image
Dyadic and BRIG BIO Sign Development & Commercialization Agreement to Bring Animal-Free Bovine Alpha-Lactalbumin to Global Nutrition Markets
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic Applied BioSolutions Announces Milestone Achievements and Recent Company Developments
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic to Present at Investor Conferences and BPI East
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
UPDATE: Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic International, Inc. Announces Proposed Public Offering of Common Stock
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic International, Inc. Announces Strategic Rebrand to Dyadic Applied BioSolutions
From Dyadic Applied BioSolutions
Via Business Wire
News headline image
Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic to Present at World Vaccine Congress | Washington
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Power Nickel (TSX.V: PNPN) – Undervalued Precious, Battery, Energy and Base Metals Play Amidst Gold Surge – More Stocks Inside
Via AB Newswire
News headline image
Breakthroughs and Discoveries: TNON, PNPN.V, POAI, DYAI, PRSO, Drive Innovation Across Sectors
Via AB Newswire
Topics Artificial Intelligence
News headline image
Dyadic (NASDAQ: DYAI) Secures $3M Gates Foundation Grant to Advance Global Vaccines & Therapeutics with C1 Fungal Platform – More Stocks Inside
Via AB Newswire
News headline image
Dyadic Announces Funding Award from CEPI to Use C1 to Accelerate Development of Protein-Based Vaccines
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March 26, 2025
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic to Attend Multiple Industry Events in March
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic Provides Business Update; Dyadic to Attend the 43rd Annual J.P. Morgan Healthcare Conference
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology
Grant Received from the Bill & Melinda Gates Foundation to Fund Development of Affordable Therapeutics 
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic Expands Global Presence with Participation in Key Industry Events
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic Provides Alternative Proteins Business Update and Announces Attendance at Bioprocess International Conference
From Dyadic International, Inc.
Via GlobeNewswire
SmallCap Tech/Biotech Stocks July/Aug 2024: ZVSA, DYAI, ZVRA, PRSO, RLMD, VTAK, ENTO, INBS, KAVL
Via AB Newswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.